Technical Analysis for FRLN - Freeline Therapeutics Holdings plc

Grade Last Price % Change Price Change
B 6.48 0.00% 0.00
FRLN closed unchanged on Friday, February 16, 2024, on 31 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat

Date Alert Name Type % Chg
Boomer Buy Setup Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Freeline is a clinical-stage biotechnology company focused on AAV-based gene therapy targeting the liver. Its vision is to create better lives for people suffering from chronic, systemic diseases using the potential of gene therapy as a one-time treatment to provide a potential functional cure. Freeline is headquartered in the U.K. and has operations in Germany and the U.S.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Gene Therapy Medical Genetics Applied Genetics Gene Delivery Gene Therapy Of The Human Retina Systemic Diseases

Is FRLN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.7
52 Week Low 2.11
Average Volume 18,474
200-Day Moving Average 4.58
50-Day Moving Average 6.40
20-Day Moving Average 6.43
10-Day Moving Average 6.45
Average True Range 0.05
RSI (14) 60.94
ADX 39.22
+DI 20.24
-DI 8.46
Chandelier Exit (Long, 3 ATRs) 6.33
Chandelier Exit (Short, 3 ATRs) 6.52
Upper Bollinger Bands 6.49
Lower Bollinger Band 6.38
Percent B (%b) 0.91
BandWidth 1.79
MACD Line 0.04
MACD Signal Line 0.04
MACD Histogram -0.0022
Fundamentals Value
Market Cap 28.24 Million
Num Shares 4.36 Million
EPS -11.40
Price-to-Earnings (P/E) Ratio -0.57
Price-to-Sales 44.81
Price-to-Book 0.93
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.50
Resistance 3 (R3) 6.50 6.49 6.49
Resistance 2 (R2) 6.49 6.49 6.49 6.49
Resistance 1 (R1) 6.49 6.49 6.49 6.49 6.49
Pivot Point 6.48 6.48 6.48 6.48 6.48
Support 1 (S1) 6.48 6.48 6.48 6.48 6.47
Support 2 (S2) 6.47 6.48 6.47 6.47
Support 3 (S3) 6.47 6.47 6.47
Support 4 (S4) 6.47